TMCI · Treace Medical Concepts, Inc.
$4.00
-0.05 (-1.23%)
At close · Jul 24
Market Cap
$259.49M
Shares
64.87M
Income-statement, balance-sheet and cash-flow figures extracted from the company's SEC filings — 10-K annual and 10-Q quarterly reports — and standardised for comparison across periods.
Revenue
$212.69M
+1.6%
FY2025
Net Income
-$59M
-5.8%
FY2025
Gross Margin
79.81%
-0.6pp
FY2025
Operating Margin
-25.46%
+1.1pp
FY2025
Diluted EPS
-$0.93
-3.3%
FY2025
Operating Cash Flow
-$15.97M
+57%
FY2025
Chart any reported metric, KPI or segment over time — the full statement history lives here
Search above to add metrics — fundamentals, product and segment revenue, company KPIs, valuation.
| Line Item | FY2026 (G) | TTM | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 |
|---|---|---|---|---|---|---|---|---|---|
| $202M – $212M | $207.32M | $212.69MG | $209.36M | $187.12M | $141.84M | $94.42M | $57.37M | $39.42M | |
| — | $42.05M | $42.94M | $41.09M | $35.18M | $25.53M | $16.89M | $12.47M | $7.63M | |
| — | $165.27M | $169.75M | $168.26M | $151.94M | $116.31M | $77.53M | $44.9M | $31.79M | |
| — | — | 79.81% | 80.37% | 81.2% | 82% | 82.11% | 78.26% | 80.64% | |
| — | $19.34M | $20.28M | $20.59M | $15.44M | $13.58M | $10.2M | $5.85M | $5.07M | |
| — | $138.53M | $140.88M | $147.64M | $140.89M | $104.57M | $65.41M | $31.65M | $25.79M | |
| — | $63.13M | $62.74M | $55.72M | $47.03M | $33M | $18.43M | $6.54M | $4.46M | |
| — | — | $1M | $1M | $500K | $0 | — | — | — | |
| — | — | $10.62M | $8.42M | $5.35M | $2.13M | $685K | $1.21M | $793K | |
| — | $221.01M | $223.91M | $223.95M | $203.37M | $151.15M | $94.04M | $44.04M | $35.32M | |
| — | -$55.74M | -$54.15M | -$55.69M | -$51.43M | -$34.84M | -$16.51M | $855K | -$3.54M | |
| — | — | -25.46% | -26.6% | -27.48% | -24.57% | -17.49% | 1.49% | -8.97% | |
| — | — | -$43.53M | -$47.27M | -$46.08M | -$32.71M | -$15.83M | $2.07M | -$2.74M | |
| — | $5.58M | $5.32M | $5.26M | $5.17M | $4.4M | $4.06M | $2.78M | $841K | |
| — | -$5.3M | -$4.85M | -$55K | $1.9M | -$7.97M | -$4.04M | -$4.52M | -$730K | |
| — | — | $0 | $0 | $0 | $0 | $0 | $0 | $0 | |
| — | -$61.04M | -$59M | -$55.74M | -$49.53M | -$42.82M | -$20.55M | -$3.67M | -$4.27M | |
| — | — | -27.74% | -26.63% | -26.47% | -30.19% | -21.77% | -6.39% | -10.82% | |
| — | — | — | — | -$49.53M | -$42.82M | -$20.75M | -$4.31M | -$4.91M | |
| — | -$61.12M | -$59.03M | -$55.81M | -$49.34M | -$42.84M | -$20.75M | -$4.31M | — | |
| USD/shares | — | — | -$0.93 | -$0.90 | -$0.81 | -$0.77 | -$0.43 | -$0.12 | — |
| USD/shares | — | — | -$0.93 | -$0.90 | -$0.81 | -$0.77 | -$0.43 | -$0.12 | — |
| shares | — | — | 63.27M | 62.11M | 60.85M | 55.28M | 48.42M | 37.07M | 36.91M |
| shares | — | — | 63.27M | 62.11M | 60.85M | 55.28M | 48.42M | 37.07M | 36.91M |
Italic rows are computed from reported lines — open a row's info icon for its formula. Values reflect the latest filing (restatements included); per-share figures on today's split basis. Click a value for its source filing.
TTM: trailing twelve months through the latest reported quarter — flows sum the last four quarters, balances take the latest. 3Y/5Y/10Y columns are trailing CAGR from the newest fiscal year; blank where an endpoint is missing or negative. (G): the company's own guidance — a (G) column is a guided period not yet reported; a G marker shows how the reported figure landed against the guided range. Non-GAAP-basis guidance (*) is shown as stated and never judged against GAAP actuals.
Price & Valuation
Multiples computed on the strict TTM/EV methodology — today's snapshot against the industry, and each ratio recomputed as of past filing dates.
Valuation
EV/Revenue
—
Medical Devices median 2.14×
EV/EBIT
—
Medical Devices median 21.03×
P/E (TTM)
—
Medical Devices median 27.62×